We are live on ! Find out more
ISL

Ingalls & Snyder LLC Portfolio holdings

AUM $2.83B
1-Year Est. Return 21.61%
This Fund
S&P 500
This Quarter Est. Return
+5.67%
1 Year Est. Return
+21.61%
3 Year Est. Return
+166.27%
5 Year Est. Return
+212.01%
10 Year Est. Return
+695.23%
AUM
$1.95B
AUM Growth
+$108M
Cap. Flow
+$36.7M
Cap. Flow %
1.88%
Top 10 Hldgs %
38.39%
Holding
457
New
17
Increased
108
Reduced
186
Closed
24

Top Buys

Rank Stock Value
1
CORT icon
Corcept Therapeutics
CORT
+$33.9M
2
CNQ icon
Canadian Natural Resources
CNQ
+$5.27M
3
PXD
Pioneer Natural Resource Co.
PXD
+$4.97M
4
PAAS icon
Pan American Silver
PAAS
+$3.54M
5
OMER icon
Omeros
OMER
+$3.53M

Top Sells

Rank Stock Value
1
CNCE
Concert Pharmaceuticals, Inc.
CNCE
+$7.57M
2
INTC icon
Intel
INTC
+$951K
3
HXL icon
Hexcel
HXL
+$791K
4
NVEI
Nuvei Corporation Subordinate Voting Shares
NVEI
+$777K
5
MSFT icon
Microsoft
MSFT
+$687K

Sector Composition

Rank Sector Weight
1 Healthcare 21.25%
2 Energy 17.15%
3 Technology 13.62%
4 Financials 12.38%
5 Industrials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OHI icon
376
Omega Healthcare
OHI
$15.1B
$216K 0.01%
7,896
– –
KR icon
377
Kroger
KR
$35.4B
$212K 0.01%
+4,289
New +$196K
MLI icon
378
Mueller Industries
MLI
$14.7B
$209K 0.01%
+11,400
New +$199K
COF icon
379
Capital One
COF
$128B
$208K 0.01%
2,158
– –
K
380
DELISTED
Kellanova
K
$206K 0.01%
+3,282
New +$207K
MO icon
381
Altria Group
MO
$114B
$206K 0.01%
4,608
-266
-5% -$12.2K
WEC icon
382
WEC Energy
WEC
$35.7B
$202K 0.01%
2,130
-34
-2% -$3.15K
WRB icon
383
W.R. Berkley
WRB
$26.9B
$202K 0.01%
4,865
-124
-2% -$5.55K
ESTC icon
384
CALL
Elastic
ESTC
$6.84B
$185K 0.01%
3,200
– –
IDN icon
385
Intellicheck
IDN
$73.1M
$180K 0.01%
72,081
-7,000
-9% -$17.3K
FHN icon
386
First Horizon
FHN
$12.2B
$178K 0.01%
+10,000
New +$222K
FSM icon
387
Fortuna Silver Mines
FSM
$2.55B
$160K 0.01%
42,000
– –
TGB
388
Trekor Metals
TGB
$2.48B
$158K 0.01%
95,236
-10,000
-10% -$16.6K
ABCM
389
DELISTED
Abcam PLC
ABCM
$144K 0.01%
+10,670
New +$159K
SEMR
390
DELISTED
Semrush
SEMR
$130K 0.01%
12,905
-2,360
-15% -$20.8K
AMGN icon
391
CALL
Amgen
AMGN
$208B
$121K 0.01%
500
– –
ELDN icon
392
Eledon Pharmaceuticals
ELDN
$261M
$120K 0.01%
50,849
– –
STNE icon
393
StoneCo
STNE
$2.77B
$116K 0.01%
12,195
-575
-5% -$5.5K
ALIT icon
394
Alight
ALIT
$447M
$103K 0.01%
560
-104
-16% -$19.1K
NG icon
395
NovaGold Resources
NG
$2.56B
$101K 0.01%
16,200
– –
DVAX
396
DELISTED
Dynavax Technologies
DVAX
$98K 0.01%
10,025
– –
EZPW icon
397
Ezcorp Inc
EZPW
$1.83B
$97K 0.01%
+11,243
New +$98.8K
VAPO
398
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$97K 0.01%
18,378
-382
-2% -$3.54K
DE icon
399
CALL
Deere & Co
DE
$160B
$83K ﹤0.01%
200
– –
WPRT
400
Westport Fuel Systems
WPRT
$33.4M
$82K ﹤0.01%
8,600
– –
14 15
16
17 18

Similar funds

GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
AF
Aviso Financial Toronto, Ontario, Canada $2.82B AUM 24.96% 1-Year Est. Return
AIP
Atlas Infrastructure Partners London, United Kingdom $2.84B AUM 4.75% 1-Year Est. Return
SAI
Systematic Alpha Investments Princeton, New Jersey $2.84B AUM 27.03% 1-Year Est. Return
GI
GLOBALT Investments Atlanta, Georgia $2.8B AUM 21.13% 1-Year Est. Return
MWM
Meridian Wealth Management Lexington, Kentucky $2.85B AUM 31.23% 1-Year Est. Return
MSDF
Michael & Susan Dell Foundation New York $2.85B AUM 26.28% 1-Year Est. Return
SHIM
Spruce House Investment Management New York $2.8B AUM 65.68% 1-Year Est. Return

Ingalls & Snyder LLC's Q1 2023 Portfolio in Review

As of Q1 2023, Ingalls & Snyder LLC held 457 positions worth $1.95B, up 5.9% from $1.84B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Ingalls & Snyder LLC's Q1 2023 filing shows 17 new, 108 increased, 186 reduced and 24 closed positions. Its largest new stake was TSMC: 31,331 shares worth $2.91M. The largest sale was Concert Pharmaceuticals, Inc., an estimated $7.57M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Energy and Technology.

  • Ingalls & Snyder LLC's largest Q1 2023 buy was TSMC: 31,331 shares worth $2.91M.
  • Ingalls & Snyder LLC added most to Corcept Therapeutics in Q1 2023, an estimated $33.9M increase.
  • Ingalls & Snyder LLC's biggest Q1 2023 reduction was Intel, cutting an estimated $951K.
  • Ingalls & Snyder LLC fully exited Concert Pharmaceuticals, Inc. in Q1 2023, selling an estimated $7.57M.
  • Ingalls & Snyder LLC's ten largest holdings make up 38% of its $1.95B portfolio in Q1 2023.
  • Ingalls & Snyder LLC opened 17 new positions and closed 24 in Q1 2023.
  • Ingalls & Snyder LLC's portfolio value rose 5.9% quarter-over-quarter to $1.95B.

Based on Ingalls & Snyder LLC's 13F filing for Q1 2023, filed 9 May 2023.